Libo Xu

738 total citations
45 papers, 520 citations indexed

About

Libo Xu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Libo Xu has authored 45 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Libo Xu's work include Multi-Criteria Decision Making (4 papers), Glioma Diagnosis and Treatment (3 papers) and RNA Interference and Gene Delivery (3 papers). Libo Xu is often cited by papers focused on Multi-Criteria Decision Making (4 papers), Glioma Diagnosis and Treatment (3 papers) and RNA Interference and Gene Delivery (3 papers). Libo Xu collaborates with scholars based in China, United States and Australia. Libo Xu's co-authors include Baofeng Guo, Chun Yang, Su Ruan, Huijuan Tang, Jingjing Guo, Shanshan Hu, Xiaofeng Wang, Jiye Cai, Ding Wang and Hang Liang and has published in prestigious journals such as Chemical Engineering Journal, Small and Journal of Medicinal Chemistry.

In The Last Decade

Libo Xu

40 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Libo Xu China 13 252 133 124 56 53 45 520
Jin-Wan Park South Korea 6 257 1.0× 85 0.6× 94 0.8× 33 0.6× 56 1.1× 38 416
Krzysztof Fujarewicz Poland 12 388 1.5× 109 0.8× 138 1.1× 59 1.1× 27 0.5× 41 661
Lixia Wu China 11 176 0.7× 130 1.0× 100 0.8× 47 0.8× 23 0.4× 39 373
Panagiotis Apostolou Greece 15 256 1.0× 209 1.6× 165 1.3× 50 0.9× 22 0.4× 42 565
Ling‐Yuh Huw United States 15 254 1.0× 273 2.1× 142 1.1× 81 1.4× 44 0.8× 26 654
Kübra Karagoz United States 14 496 2.0× 117 0.9× 250 2.0× 60 1.1× 25 0.5× 25 685
Daiki Taniyama Japan 14 277 1.1× 267 2.0× 123 1.0× 108 1.9× 13 0.2× 46 527
P. Ravazoula Greece 13 138 0.5× 93 0.7× 103 0.8× 35 0.6× 25 0.5× 42 598
Francesco Alfredo Zito Italy 17 276 1.1× 189 1.4× 153 1.2× 132 2.4× 17 0.3× 48 722
Agnese Latorre Italy 18 297 1.2× 429 3.2× 277 2.2× 135 2.4× 43 0.8× 51 1.0k

Countries citing papers authored by Libo Xu

Since Specialization
Citations

This map shows the geographic impact of Libo Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Xu more than expected).

Fields of papers citing papers by Libo Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Libo Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Xu. The network helps show where Libo Xu may publish in the future.

Co-authorship network of co-authors of Libo Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Libo Xu. A scholar is included among the top collaborators of Libo Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Libo Xu. Libo Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Libo, Mao Li, Zhenhao Wang, & Qingsong Li. (2025). Global trends and burden of idiopathic epilepsy: regional and gender differences from 1990 to 2021 and future outlook. Journal of Health Population and Nutrition. 44(1). 45–45. 2 indexed citations
2.
Xu, Libo, et al.. (2024). A Training-Free Latent Diffusion Style Transfer Method. Information. 15(10). 588–588. 1 indexed citations
3.
Xu, Libo, Zhenhao Wang, Wenchao Wu, Mao Li, & Qingsong Li. (2024). Global, regional, and national burden of intracerebral hemorrhage and its attributable risk factors from 1990 to 2021: results from the 2021 Global Burden of Disease Study. BMC Public Health. 24(1). 2426–2426. 20 indexed citations
4.
Sun, Xiaofan, Peng Chen, Zheng Tang, et al.. (2024). Halide Anions Tuning of Lead‐Free Perovskite‐Type Ferroelectric Semiconductors with Inverse High‐Temperature Symmetry Breaking. Small. 20(29). e2310768–e2310768. 6 indexed citations
5.
Fan, Chang‐Chun, Junjie Jiang, Zheng Tang, et al.. (2023). Metal-free chiral molecular ferroelectric photovoltaics. Chemical Engineering Journal. 477. 146805–146805. 5 indexed citations
6.
Xu, Libo, Ling Zhang, Shengnan Zhang, et al.. (2023). Taxifolin inhibits melanoma proliferation/migration impeding USP18/Rac1/JNK/β-catenin oncogenic signaling. Phytomedicine. 123. 155199–155199. 8 indexed citations
7.
Xu, Libo, et al.. (2022). A non-definitive auto-transfer mechanism for arbitrary style transfers. Knowledge-Based Systems. 260. 110171–110171. 4 indexed citations
8.
Xu, Libo, et al.. (2022). Single stage object detection algorithm based on fusing strategy optimization selection and dual attention mechanism. Journal of Image and Graphics. 27(8). 2430–2443. 2 indexed citations
9.
Xu, Libo, Ling Zhang, Jicheng Sun, et al.. (2022). Roles for the methyltransferase SETD8 in DNA damage repair. Clinical Epigenetics. 14(1). 34–34. 12 indexed citations
10.
Lu, Jianxun, et al.. (2022). Far-field scattering regulation of all dielectric material metagratings based on the addition principle of coding elements. Journal of Electromagnetic Waves and Applications. 36(17). 2435–2449. 1 indexed citations
11.
Li, Mengxin, Dong Eun Song, Xuanzhong Wang, et al.. (2022). RSL3 triggers glioma stem cell differentiation via the Tgm2/AKT/ID1 signaling axis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1868(12). 166529–166529. 14 indexed citations
12.
Li, Mengxin, Xuanzhong Wang, Xiaodong Wei, et al.. (2021). RSL3 enhances the antitumor effect of cisplatin on prostate cancer cells via causing glycolysis dysfunction. Biochemical Pharmacology. 192. 114741–114741. 45 indexed citations
13.
Liang, Hang, Qian Wang, Ding Wang, et al.. (2020). RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7. Biochemical Pharmacology. 180. 114118–114118. 14 indexed citations
14.
Wang, Qian, Shengnan Jia, Yan Jiao, et al.. (2019). SSRP1 influences colorectal cancer cell growth and apoptosis via the AKT pathway. International Journal of Medical Sciences. 16(12). 1573–1582. 13 indexed citations
15.
Xu, Libo, Lin Qiao, Feng Zhao, et al.. (2019). Improvement and Application of Apriori Algorithm Based on Equalization. 635–641. 1 indexed citations
16.
Zhao, Yanying, Libo Xu, Baofeng Guo, et al.. (2018). Synergistic Suppression of Melanoma Growth by a Combination of Natural dsRNA and Panaxadiolsaponins. Journal of Interferon & Cytokine Research. 38(9). 378–387. 1 indexed citations
17.
Xu, Libo, Jinguo Wang, Baofeng Guo, et al.. (2017). Comparison of clinical and survival characteristics between prostate cancer patients of PSA-based screening and clinical diagnosis in China. Oncotarget. 9(1). 428–441. 11 indexed citations
18.
Wang, Hongliang, Baofeng Guo, Jinsha Liu, et al.. (2017). Inhibition of prostate cancer RM1 cell growth in vitro by hydroxyapatite nanoparticle-delivered short hairpin RNAs against Stat3. Molecular Medicine Reports. 16(1). 459–465. 7 indexed citations
19.
Xu, Libo, Jiateng Zhong, Baofeng Guo, et al.. (2016). miR-96 promotes the growth of prostate carcinoma cells by suppressing MTSS1. Tumor Biology. 37(9). 12023–12032. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026